Skip to main content
. Author manuscript; available in PMC: 2018 Jan 1.
Published in final edited form as: Catheter Cardiovasc Interv. 2016 May 18;89(1):102–111. doi: 10.1002/ccd.26585

Table 5.

Outcomes by device chosen

ASO
n=1098
HSO
n=333
GSO
n=81
Other
n=52
p
Technical failure 5.8% (64) 6.9% (23) 3.7% (3) 1.9% (1) 0.42
  Release and retrieve 3.8% (42) 3.6% (12) 2.5% (2) 0% (0) 0.49
  Embolization 1.6% (17) 3.0% (10) 1.2% (1) 1.9% (1) 0.37
  Malposition 0.4% (4) 0.3% (1) 0.0% (0) 0.0% (0) 0.92
  Residual shunt (>3mm) 1.8% (20) 0.6% (2) 0.0% (0) 0.0% (0) 0.19
Major early adverse event 3.7% (41) 4.5% (15) 1.2% (1) 9.6% (5) 0.10
  Cardiac arrest 0.2% (2) 0.0% (0) 0.0% (0) 0.0% (0) 0.84
  Arrhythmia 1.7% (19) 2.1% (7) 1.2% (1) 7.7% (4) 0.03
  Tamponade 0.2% (2) 0.0% (0) 0.0% (0) 0.0% (0) 0.84
  Bleeding event 0.8% (9) 0.6% (2) 1.2% (1) 0.0% (0) 0.85
  Transfusion 0.4% (4) 0.0% (0) 0.0% (0) 0.0% (0) 0.64
  Vascular complication 0.2% (4) 0.1% (1) 0.0% (0) 1.0% (1) 0.38
  Unplanned cardiac surgery 1.0% (19) 0.6% (4) 0.0% (0) 1.0% (1) 0.53
  Unplanned other surgery 0.1% (2) 0.0% (0) 0.0% (0) 1.0% (1) 0.05
  Subsequent cardiac
  catheterization
0.4% (8) 1.2% (8) 0.0% (0) 0.0% (0) 0.12
  Airway event requiring
  intubation
0.1% (2) 0.0% (0) 0.0% (0) 0.0% (0) 0.81

ASO: Amplatzer septal occluder device, GSO: Gore septal occluder device or Cardioform device, HSO: Helex septal occluder device